Esperion Therapeutics
ESPR
#6296
Rank
C$1.16 B
Marketcap
C$4.86
Share price
4.87%
Change (1 day)
82.38%
Change (1 year)

Market capitalization of Esperion Therapeutics (ESPR)

Market cap: C$1.16 Billion

As of February 2026 Esperion Therapeutics has a market cap of C$1.16 Billion. This makes Esperion Therapeutics the world's 6296th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Esperion Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026C$1.16 B-11.45%
2025C$1.31 B103.46%
2024C$0.64 B42.94%
2023C$0.45 B-27.6%
2022C$0.62 B60.52%
2021C$0.38 B-54.83%
2020C$0.85 B-59.88%
2019C$2.14 B27.41%
2018C$1.68 B-22.49%
2017C$2.16 B471.48%
2016C$0.37 B-45.42%
2015C$0.69 B-27.17%
2014C$0.95 B325.49%
2013C$0.22 B

End of Day market cap according to different sources

On Feb 1st, 2026 the market cap of Esperion Therapeutics was reported to be:

C$1.10 Billion
by Nasdaq info icon info icon
C$1.09 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
C$205.63 B 17,605.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$109.18 B 9,300.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
C$3.24 B 179.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
C$0.61 B-47.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
C$6.13 B 427.84%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$15.33 B 1,220.37%๐Ÿ‡บ๐Ÿ‡ธ USA